Semin Reprod Med 2000; 18(1): 005-010
DOI: 10.1055/s-2000-13470
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Mutations in the Follicle-Stimulating Hormone-Beta (FSHβ) and FSH Receptor Genes in Mice and Humans

Lawrence C. Layman
  • Department of Obstetrics & Gynecology, Section of Reproductive Endocrinology, Infertility, and Genetics, Developmental Biology Program, The Institute of Molecular Medicine and Genetics, The Medical College of Georgia, Augusta, Georgia
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. Dezember 2000 (online)

ABSTRACT

Follicle-stimulating hormone (FSH), a dimeric glycoprotein synthesized in the anterior pituitary gland, is important for the production of sex steroids and gametes. FSH-beta (FSHβ) and FSH receptor (FSHR) knockout mice display impaired ovarian follicular development and infertility in females and small testes, oligospermia, and fertility in males. Humans with FSHβ gene mutations tend to have a more severe phenotype than those with FSHR gene mutations, although infertility and varying degrees of impaired sex steroid production occur in both types of mutations. Data from human and mouse mutations in the FSHβ and FSHR genes suggest that FSH is necessary for normal pubertal development and fertility in males and females.

REFERENCES

  • 1 Huhtaniemi I T, Aittomaki K. Mutations of follicle-stimulating hormone and its receptor: effects on gonadal function.  Eur J Endocrinol . 1998;  138 473-481
  • 2 Kumar T R, Wang Y, Lu N, Matzuk M M. Follicle-stimulating hormone is required for ovarian follicle maturation but not male fertility.  Nat Genet . 1997;  15 201-204
  • 3 Kumar T R, Low M J, Matzuk M M. Genetic rescue of follicle-stimulating hormone β-deficient mice.  Endocrinology . 1998;  139 3289-3295
  • 4 Dierich A, Sairam M R, Monaco L. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance.  Proc Natl Acad Sci U S A . 1998;  95 13612-13617
  • 5 Matthews C H, Borgato S, Beck-Peccoz P. Primary amenorrhea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone.  Nat Genet . 1993;  5 83-86
  • 6 Layman L C, Lee E J, Peak D B. Delayed puberty and hypogonadism caused by a mutation in the follicle stimulating hormone β-subunit gene.  N Engl J Med . 1997;  337 607-611
  • 7 Lindstedt G, Nystrom E, Matthews C, Ernest I, Janson P O, Chatterjee K. Follitropin (FSH) deficiency in an infertile male due to FSHbeta gene mutation: a syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations.  Clin Chem Lab Med . 1998;  36 663-665
  • 8 Matthews C, Chatterjee V K. Isolated deficiency of follicle-stimulating hormone re-revisited.  N Engl J Med . 1997;  337 642
  • 9 Phillip M, Arbelle J E, Segev Y, Parvari R. Male hypogonadism due to a mutation in the gene for the β-subunit of follicle stimulating hormone.  N Engl J Med . 1998;  338 1729-1732
  • 10 Barnes R B, Namnoum A B, Cunningham J M, Rosenfield R L, Layman L C. Reproductive endocrine evaluation of a patient with FSHβ mutation: lack of ovarian androgen excess despite elevated LH levels.  J Soc Gynecol Invest . 1999;  6 A208,634
  • 11 Barnes R B, Namnoum A, Rosenfield R L, Layman L C. Effect of follicle-stimulating hormone on ovarian androgen production in a woman with isolated follicle-stimulating hormone deficiency.  N Engl J Med . 2000;  343 1197-1198
  • 12 Aittomaki K, Lucena J LD, Pakarinen P. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic hypogonadism.  Cell . 1995;  82 959-968
  • 13 Beau I, Touraine P, Meduri G. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor.  J Clin Invest . 1998;  102 1352-1359
  • 14 Tapanainen J S, Aittomaki K, Min J, Vaskivuo T, Huhtaniemi I T. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility.  Nat Genet . 1997;  15 205-206
  • 15 Gromoll J, Simoni M, Nieschlag E. An activating mutation of the follicle stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man.  J Clin Endocrinol Metab . 1996;  81 1367-1370
  • 16 Aittomaki K, Herva R, Stenman U-H. Clinical features of primary ovarian failure caused by a point mutation in the follicle stimulating hormone receptor gene.  J Clin Endocrinol Metab . 1996;  81 3722-3726
  • 17 Touraine P, Beau I, Gougeon A. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype.  Mol Endocrinol . 1999;  13 1844-1854
  • 18 Jiang M, Aittomaki K, Nilsson C. The frequency of an inactivating point mutation (566C-T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry.  J Clin Endocrinol Metab . 1998;  83 4338-4343
  • 19 Layman L C, Amde S, Cohen D P, Jin M, Xie J. The Finnish follicle stimulating hormone receptor (FSHR) gene mutation in women with 46,XX ovarian failure is rare in the United States.  Fertil Steril . 1998;  69 300-302
  • 20 Liu J Y, Gromoll J, Cedars M I, La Barbera R A. Identification of allelic variants in the follicle-stimulating hormone receptor genes of females with or without hypergonadotropic amenorrhea.  Fertil Steril . 1998;  70 326-331
  • 21 Conway G S, Conway E, Walker C, Hoppner W, Gromoll J, Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary.  Clin Endocrinol (Oxf) . 1999;  51 97-99
  • 22 Simoni M, Gromoll J, Hoppner W. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms.  J Clin Endocrinol Metab . 1999;  84 751-755
    >